HER2 as marker for the detection of circulating tumor cells

Breast Cancer Research and Treatment

Volumn 117, Issue 3, 2009, Pages 535-537

  Müller, Volkmar ^a   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER CELL; CANCER PATIENT; HUMAN; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 70349567025     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0276-y     Document Type: Note

References (19)

1. V Müller D Hayes K Pantel 2006 Recent translational research: circulating tumor cells in breast cancer patients Breast Cancer Res 8 110 10.1186/bcr1541 16953898 10.1186/bcr1541 (Pubitemid 44803999)
2. M Cristofanilli J Mendelsohn 2006 Circulating tumor cells in breast cancer: advanced tools for "tailored" therapy? Proc Natl Acad Sci USA 103 17073 17074 10.1073/pnas.0608651103 17090687 10.1073/pnas.0608651103 1:CAS:528:DC%2BD28Xht1Ogt77E (Pubitemid 44788923)
3. S Apostolaki M Perraki G Kallergi M Kafousi S Papadopoulos A Kotsakis A Pallis N Xenidis L Kalmanti K Kalbakis S Agelaki A Kalykaki C Stournaras E Stathopoulos V Georgoulias D Mavroudis 2008 Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance Breast Can Res Treat 10.1007/s10549-008-0239-3
4. S Meng D Tripathy S Shete R Ashfaq B Haley S Perkins P Beitsch A Khan D Euhus C Osborne E Frenkel S Hoover M Leitch E Clifford E Vitetta L Morrison D Herlyn LW Terstappen T Fleming T Fehm T Tucker N Lane J Wang J Uhr 2004 HER-2 gene amplification can be acquired as breast cancer progresses Proc Natl Acad Sci USA 101 9393 9398 10.1073/pnas.0402993101 15194824 10.1073/pnas.0402993101 1:CAS:528:DC%2BD2cXltlKjsL4%3D (Pubitemid 38812885)
5. DF Hayes TM Walker B Singh ES Vitetta JW Uhr S Gross C Rao GV Doyle LW Terstappen 2002 Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer Int J Oncol 21 1111 1117 12370762 1:CAS:528:DC%2BD38XosFSrtro%3D
6. S Apostolaki M Perraki A Pallis V Bozionelou S Agelaki P Kanellou A Kotsakis E Politaki K Kalbakis A Kalykaki L Vamvakas V Georgoulias D Mavroudis 2007 Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance Ann Oncol 18 851 858 10.1093/annonc/mdl502 17301075 10.1093/annonc/mdl502 1:STN:280: DC%2BD2s3ns1Kksw%3D%3D (Pubitemid 47054081)
7. A Stathopoulou I Vlachonikolis D Mavroudis M Perraki C Kouroussis S Apostolaki N Malamos S Kakolyris A Kotsakis N Xenidis D Reppa V Georgoulias 2002 Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance J Clin Oncol 20 3404 3412 10.1200/JCO.2002.08.135 12177100 10.1200/JCO.2002.08.135 1:CAS:528:DC%2BD38XntVyjsbg%3D (Pubitemid 34894673)
8. N Xenidis M Perraki M Kafousi S Apostolaki I Bolonaki A Stathopoulou K Kalbakis N Androulakis C Kouroussis T Pallis C Christophylakis K Argyraki ES Lianidou S Stathopoulos V Georgoulias D Mavroudis 2006 Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients J Clin Oncol 24 3756 3762 10.1200/JCO.2005.04.5948 16769987 10.1200/JCO.2005.04. 5948 1:CAS:528:DC%2BD28XpsVaqs78%3D (Pubitemid 46622314)
9. S Riethdorf H Fritsche V Müller T Rau C Schindlbeck B Rack W Janni C Coith K Beck F Janicke S Jackson T Gornet M Cristofanilli K Pantel 2007 Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the cellsearch system Clin Cancer Res 13 920 928 10.1158/1078-0432.CCR-06-1695 17289886 10.1158/1078-0432.CCR-06-1695 1:CAS:528:DC%2BD2sXhsVyrsL0%3D (Pubitemid 46340368)
10. Rack BK, Schindlbeck C, Schneeweiss A, Hilfrich J, Lorenz R, Beckmann MW, Pantel K, Lichtenegger W, Sommer HL, Janni WJ (2008) Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: the German SUCCESS-Trial. J Clin Oncol 26: Abstract 503
11. JY Pierga FC Bidard C Mathiot E Brain S Delaloge S Giachetti P de Cremoux R Salmon A Vincent-Salomon M Marty 2008 Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial Clin Cancer Res 14 7004 7010 10.1158/1078-0432.CCR-08-0030 18980996 10.1158/1078-0432.CCR-08-0030 1:CAS:528:DC%2BD1cXhtlens7bL
12. S Nagrath LV Sequist S Maheswaran DW Bell D Irimia L Ulkus MR Smith EL Kwak S Digumarthy A Muzikansky P Ryan UJ Balis RG Tompkins DA Haber M Toner 2007 Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 450 1235 1239 10.1038/nature06385 18097410 10.1038/nature06385 1:CAS:528:DC%2BD2sXhsVGjsL%2FK
13. K Pachmann O Camara A Kavallaris S Krauspe N Malarski M Gajda T Kroll C Jorke U Hammer A Altendorf-Hofmann C Rabenstein U Pachmann I Runnebaum K Hoffken 2008 Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse J Clin Oncol 26 1208 1215 10.1200/JCO.2007.13.6523 18323545 10.1200/JCO.2007.13.6523
14. T Jotsuka Y Okumura S Nakano H Nitta T Sato M Miyachi K Suzumura J Yamashita 2004 Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer Surgery 135 419 426 10.1016/j.surg.2003.08.014 15041966 10.1016/j.surg.2003.08.014 (Pubitemid 38453497)
15. M Ignatiadis M Perraki S Apostolaki E Politaki N Xenidis M Kafousi E Stathopoulos E Lianidou C Sotiriou V Georgoulias D Mavroudis 2007 Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer Clin Breast Cancer 7 883 889 10.3816/CBC.2007.n.054 18269779 10.3816/CBC.2007.n.054
16. M Ignatiadis N Xenidis M Perraki S Apostolaki E Politaki M Kafousi EN Stathopoulos A Stathopoulou E Lianidou G Chlouverakis C Sotiriou V Georgoulias D Mavroudis 2007 Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer J Clin Oncol 25 5194 5202 17954712 10.1200/JCO.2007.11.7762 (Pubitemid 350232250)
17. M Ignatiadis G Kallergi M Ntoulia M Perraki S Apostolaki M Kafousi G Chlouverakis E Stathopoulos E Lianidou V Georgoulias D Mavroudis 2008 Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer Clin Cancer Res 14 2593 2600 10.1158/1078-0432.CCR-07-4758 18451221 10.1158/1078-0432.CCR-07-4758 1:CAS:528:DC%2BD1cXlsV2qsb0%3D
18. G Wiedswang E Borgen C Schirmer R Karesen G Kvalheim JM Nesland B Naume 2006 Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer Int J Cancer 118 2013 2019 10.1002/ijc.21576 16287086 10.1002/ijc.21576 1:CAS:528:DC%2BD28Xjt1GqurY%3D
19. P Wülfing J Borchard H Buerger S Heidl KS Zanker L Kiesel B Brandt 2006 HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients Clin Cancer Res 12 1715 1720 10.1158/1078-0432.CCR-05-2087 16551854 10.1158/1078-0432.CCR-05-2087